dications for the various regimens available for the treatment of tumours of the head and neck. Until this evidence is available inappropriate management will continue to be given in some cases. A patient's first treatment is vital and dictates the whole prognosis of his disease, but at present this is selected by the clinician who first examines him and who, lacking data from controlled trials, usually chooses the treatment with which he is most familiar.
Introduction
Lithium salts are used for the treatment and prophyiaxis of recurrent manic-depressive disorders . During lithium administration the serum levels of lithium must be maintained within a relatively narrow range: low levels lack effect and high levels are associated with a risk of side effects or intoxication. Lithium is excreted almost exclusively through the kidneys and the serum lithium level is therefore determined by the maintenance dosage and the renal elimination of lithium. Drugs and procedures which alter the renal lithium clearance are potentially dangerous to patients on lithium treatment. Among such drugs may be the diuretics.
In Denmark 11% of the population over 50 years of age take diuretics regularly (Skovbo et al., 1972) . Diuretic drugs may be prescribed to manic-depressive patients on lithium treatment if they develop hypertension or oedema; lithium treatment itself occasionally leads to oedema formation (Demers and Heninger, 1970 J7ournal, 1974) .
The effect of diuretic drugs on the renal lithium clearance has been examined in healthy human subjects and rats. Single doses of frusemide, bendrofluazide, and ethacrynic acid given to the human subjects failed to affect the lithium clearance significantly (Thomsen and Schou, 1968) . Daily administration of hydrochlorothiazide to rats over two to four weeks led to a reduction of the lithium clearance by 30-35% (Thomsen and Schou, 1973) .
We have examined whether the renal lithium clearance is influenced by long-term administration of thiazides given in ordinary therapeutic doses to patients.
Patients and Methods
Altogether 22 patients (8 men and 14 women) were studied. They were admitted to the department of internal medicine at Thisted Centralsygehus during February to September 1973. All had oedema from various causes for which prolonged thiazide treatment was indicated.
Determinations of lithium clearance (after the administration of a-small test dose of lithium carbonate), creatinine clearance, and urinary sodium excretion were carried out twice at intervals of about two months during and before or after treatment with thiazides. The thiazides used were hydroflumethiazide (Rontyl) and bendrofluazide (Centyl). Hydroflumethiazide was given in a dosage of 25 mg daily together with 3-4 g of potassium chloride; the bendrofluazide dosage was 2-5 mg daily. Clearance determinations during thiazide treatment were carried out after treatment periods of two months or longer, determinations after the discontinuance of thiazides being carried out when the patients had been without treatment for two months.
The patients had ordinary hospital food except on the days of examination, when they avoided caffeine-containing food, drinks, and drugs.
The examination procedure was as follows. At 9 p.m. the patients emptied their bladder, the urine sample being discarded. They then took 600 mg of lithium carbonate by mouth; this corresponds to 16-2 mmol of lithium. During the next 11 hours urine was collected for determination of the night creatinine clearance. At 8 a.m. a blood sample was drawn for determination of the serum lithium and creatinine concentrations.
During the next seven hours urine was again collected for determination of the lithium clearance, the day creatinine clearance, and the urinary sodium excretion. At 3 p.m. a second blood sample was drawn for determination of the serum lithium and creatinine concentrations. The whole procedure was then repeated during the next 24 hours, starting at 9 p.m.
Lithium concentrations in the serum and urine were determined by flame photometry according to the methods of Amdisen (1967 Amdisen ( , 1971 . Determinations were carried out in duplicate; relative standard deviations were about 10%. Lithium clearances were calculated as described by Thomsen and Schou (1968) . Sodium concentrations in the urine were determined by flame photometry. Creatinine concentrations in the serum and urine were determined with the alkaline picrate method.
In some instances the creatinine clearance showed such wide variation between day and night or between two consecutive days that incomplete emptying of the bladder was suspected. Such values were excluded from the study; exclusion was decided by a person who did not know whether the patient was on thiazide treatment at the time of examination. Urinary sodium excretion (,umol/min) Renal lithium clearances plotted against urinary sodium excretions ofpatients during and before or after treatment with thiazide.
Results
Renal lithium clearances of the patients during and before or after treatment with thiazides are shown in table I. For the group as a whole the mean lithium clearance decreased significantly from 20-2 to 15-4 ml/min during thiazide treatment, a fall of 24%. For the 12 patients with paired observations the mean lithium clearance decreased from 19-8 to 15-7 ml/minthat is, 21 0/ . This failed to reach statistical significance. It had previously been shown that the renal lithium clearance is correlated with the creatinine clearance and with the urinary excretion of sodium (Thomsen and Schou, 1968; Thomsen et al., 1969; Geisler et al., 1971) . We therefore examined whether the fall in the lithium clearance during thiazide treatment could be accounted for by a change in one of these variables.
The mean creatinine clearance was essentially the same whether the patients were on thiazide treatment (78 ml/min) or not (84 ml/min). The mean urinary sodium excretion was somewhat higher during thiazide treatment (147 emol/min) than before or after treatment (121 ieumol/min). The lithium clearances are plotted in the chart against urinary sodium excretions. The following mechanism may underlie this phenomenon. Initially during thiazide treatment sodium excretion exceeds sodium intake, but this does not continue. After some days sodium excretion again equals sodium intake; this is due to a compensatory increase of sodium reabsorption in the proximal tubules. Lithium is reabsorbed with sodium in the proximal tubules (Thomsen and Schou, 1968) , where thiazides exert little or no effect. Lithium is reabsorbed little or not at all in the more distal parts of the nephron (Thomsen and Schou, 1968) , where thiazides have their main action. Long-term thiazide treatment may therefore lead to an increase in the reabsorption of lithium and a consequent decrease in the lithium clearance even under circumstances where sodium excretion is unaltered.
A reduction of the lithium clearance by 24% may well result in a rise of the serum lithium concentration to levels associated with side effects or a risk of intoxication. Thiazides, and pre- sumably also other diuretics, should therefore be used with caution in patients given lithium treatment, and long-term use should be accompanied by frequent determinations of the serum lithium concentration. If this increases, the lithium dosage should be reduced or treatment with diuretic drugs discontinued.
Introduction
The association between distinctive nodular types of radiographic opacities in the lungs of coal miners and rheumatoid arthritis was described by Caplan (1953) and confirmed in an epidemiological study by Miall et al. (1953) . Later a similar radiographic appearance was described in miners without arthritis but in whom circulating rheumatoid factor (R.F.) was present (Caplan et al., 1962) . These workers also found a slightly increased incidence of rheumatoid factor among miners with conventional progressive massive fibrosis and this was confirmed by Wagner and McCormick (1967) . An increased incidence of rheumatoid factor has also been described in asbestos workers with pulmonary fibrosis (Pernis et al., 1965; Turner-Warwick and Parkes, 1970) . TurnerWarwick and Parkes (1970) also found an increased incidence of antinuclear antibodies (A.N.A.) in asbestosis similar to that found in cryptogenic fibrosing alveolitis (Turner-Warwick and Doniach, 1965; Turner-Warwick and Haslam, 1971) .
In view of the range of radiographic abnormalities seen in coal miners, some relating to the deposition alone of coal and other mineral dust and others associated with fibrosis of the lungs, we wished to establish whether antinuclear antibody could also be found in coal miners with pneumoconiosis and if so whether it related to certain types of radiographic abnormality.
Patients and Methods
The 109 subjects (miners and ex-miners) attended the London Pneumoconiosis Medical Panel during 1971 and 1972. They were admitted to the study consecutively and without selection provided that permission to take a blood sample was given. As about equal numbers of patients were required in each radiographic category of pneumoconiosis intake was stopped as sufficient numbers in each category were obtained. For this purpose the category was judged by one of us (W.R.P.) on a preliminary reading. No patient was selected or excluded on the basis of rheumatoid arthritis or any other clinical feature. All had been accepted by the Panel as having coal pneumoconiosis.
Recording of Clinical Data.-Clinical data and the history of coal dust exposure were recorded on a standard questionnaire when the patient attended the Panel. Most of the patients had worked in mines in more than one geographical area, so that the type of coal dust exposure was mixed.
Serological Tests.-Clotted blood samples were sent from the Pneumoconiosis Medical Panel to the laboratory. Antinuclear antibody was estimated by a standard double-layer immunofluorescent technique on sections of rat liver at a screening dilution of 1/10. Titres of positive sera were estimated by serial serum dilutions using the same technique. Rheumatoid factor was estimated by the differential agglutination test (D.A.T.) (Rose et al., 1948) 
